Breaking News

OSE Immunotherapeutics, Microsoft Enter Research and Technology Collaboration

OSE to further develop its digital tools in AI and algorithmic approaches for the development of first-in-class immunotherapies.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

OSE Immunotherapeutics SA, a biotech startup, was selected by Microsoft France to be a partner of its support program for French Biotech & Deeptech Startups, which aims to support companies at the crossroads of research and technology to accelerate discovery and development. This program provides the selected startups with technical support to develop a technical framework of architecture securing scalability and startups’ data security. It also proposes a business support from Microsoft Fra...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters